Teligent Inc
(TLGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TLGT | SLGL | MGX | ||
| Company | Teligent Inc | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.2070 | 71.60 | 1.4600 | ||
| High | 0.2090 | 73.50 | 1.5100 | ||
| Low | 0.1650 | 62.08 | 1.4500 | ||
| Latest | 0.1735 | 67.20 | 1.4600 | ||
| Change | -0.0279 | -8.92 | +0.0100 | ||
| % Change | -13.85% | -11.72% | +0.69% | ||
| Volume | 73,687,200 | 25,800 | 199,200 | ||
| 20-Day Average Volume | 14,124,449 | 27,515 | 279,910 | ||
| Previous Close | 0.2014 | 76.12 | 1.4500 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3321 | 64.61 | 1.5675 | ||
| 20-Day Raw Stochastic | 3.24% | 66.36% | 17.07% | ||
| 20-Day Relative Strength | 25.55 | 58.67 | 40.21 | ||
| Weighted Alpha | -70.26 | +480.30 | -48.50 | ||
| Today's Opinion | 100% Sell | 100% Buy | 88% Sell | ||
| Previous Opinion | 100% Sell | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -44.64% since 10/08/21 | +2.16% since 02/06/26 | -5.19% since 02/06/26 | ||
| Low | 0.1650 on 10/15/21 | 60.55 on 02/09/26 | 1.4400 on 02/12/26 | ||
| High | 0.3388 on 10/13/21 | 76.80 on 02/12/26 | 1.5900 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | -55.68% since 09/15/21 | +6.77% since 01/13/26 | -15.12% since 01/13/26 | ||
| Low | 0.1650 on 10/15/21 | 48.26 on 01/23/26 | 1.3900 on 02/06/26 | ||
| High | 0.4275 on 09/30/21 | 76.80 on 02/12/26 | 1.8000 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | -65.30% since 07/15/21 | +88.90% since 11/13/25 | -14.12% since 11/13/25 | ||
| Low | 0.1650 on 10/15/21 | 32.51 on 11/19/25 | 1.3900 on 02/06/26 | ||
| High | 0.6300 on 08/04/21 | 76.80 on 02/12/26 | 1.8700 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | -69.35% since 04/15/21 | +334.81% since 08/13/25 | -24.74% since 08/13/25 | ||
| Low | 0.1650 on 10/15/21 | 14.78 on 08/14/25 | 1.3900 on 02/06/26 | ||
| High | 0.6579 on 06/14/21 | 76.80 on 02/12/26 | 3.9500 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,104 | 187,205 | 54,819 | ||
| Shares Outstanding, K | 92,817 | 2,786 | 37,547 | ||
| Annual Sales | 45,310,000 | 11,540,000 | 52,300,000 | ||
| Annual Net Income | -122,020,000 | -10,580,000 | -78,060,000 | ||
| Last Quarter Sales | 10,430,000 | 400,000 | 8,660,000 | ||
| Last Quarter Net Income | -12,870,000 | -5,940,000 | -20,390,000 | ||
| 60-Month Beta | 1.61 | 1.36 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/16/21 | -2.13 on 11/20/25 | -0.55 on 11/11/25 | ||
| Latest Earnings Date | 10/03/22 | 05/05/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||